Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor.

FEBS letters(2023)

引用 0|浏览4
暂无评分
摘要
Mycobacterium tuberculosis (MTB) is the etiologic agent of tuberculosis (TB), an ancient disease which causes 1.5 million deaths worldwide. Dihydroorotate dehydrogenase (DHODH) is a key enzyme of the MTB de novo pyrimidine biosynthesis pathway, and it is essential for MTB growth in vitro, hence representing a promising drug target. We present: i) the biochemical characterization of the full-length MTB DHODH, including the analysis of the kinetic parameters, and ii) the previously unreleased crystal structure of the protein that allowed us to rationally screen our in-house chemical library and identify the first selective inhibitor of mycobacterial DHODH. The inhibitor has fluorescence properties, potentially instrumental to in cellulo imaging studies, and exhibits and IC value of 43 μM, paving the way to hit-to-lead process.
更多
查看译文
关键词
dihydroorotate dehydrogenase, drug discovery, Mycobacterium tuberculosis, pyrimidine biosynthesis, tuberculosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要